|4Mar 8, 8:00 PM ET

Hamdy Ahmed MD 4

4 · Vincerx Pharma, Inc. · Filed Mar 8, 2024

Insider Transaction Report

Form 4
Period: 2024-03-07
Hamdy Ahmed MD
DirectorPresident and CEO10% Owner
Transactions
  • Award

    Stock Option (right to buy)

    2024-03-07+146,746146,746 total
    Exercise: $7.38Exp: 2034-03-06Common Stock (146,746 underlying)
Footnotes (1)
  • [F1]One-third (1/3) vests on March 7, 2025, with the remainder vesting in twenty-four equal monthly installments thereafter.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4